Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

• Main Authors: Ren T (Author), Shan J (Author), Li M (Author), Qing Y (Author), Qian C (Author), Wang G (Author), Li Q (Author), Lu G (Author), Li C (Author), Peng Y (Author), Luo H (Author), Zhang S (Author), Yang Y (Author), Cheng Y (Author), Wang D (Author), Zhou SF (Author)
• Formato: Livro
• Publicado em: Dove Medical Press, 2015-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Tao Ren,1–3,* Jinlu Shan,1,* Mengxia Li,1 Yi Qing,1 Chengyuan Qian,4 Guangjie Wang,5 Qing Li,1,3 Guoshou Lu,1 Chongyi Li,1 Yu Peng,1 Hao Luo,1 Shiheng Zhang,1 Yuxing Yang,1 Yi Cheng,1 Dong Wang,1 Shu-Feng Zhou31Cancer Center, Daping Hospital and Research Institute of Surgery, Third Militar...